2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P3852
    Neurokinin Receptor (393-407), rat 153607-26-2 98%
    Neurokinin Receptor (393-407), rat (SPR393–407) is a rat neurokinin 1 receptor (NK1R) fragment. NK1R is rapidly internalized by endocytosis and recycled to the plasma membrane when binding to substance P (SP). Neurokinin Receptor (393-407), rat can be used in the research of neurogenic inflammation.
    Neurokinin Receptor (393-407), rat
  • HY-P3855
    Endokinin D 566151-48-2 98%
    Endokinin D is a human tachykinin and consist of 14 amino acid residues.
    Endokinin D
  • HY-P3863
    Pancreastatin (swine) 106477-83-2
    Pancreastatin (swine) is a 49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.
    Pancreastatin (swine)
  • HY-P3872
    Peptide B, bovine 87713-86-8 98%
    Peptide B, bovine is an immunoregulatory peptide in bovine milk. Peptide B, bovine comes from αs1-casein B-8P (f1-13), is the major peptide produced during the ripening process with antihypertensive effects.
    Peptide B, bovine
  • HY-P3892
    Protein Kinase C (19-35) Peptide 309247-48-1 99.90%
    Protein Kinase C (19-35) Peptide is the PKC pseudosubstrate inhibitor/region. Protein Kinase C (19-35) Peptide possibly blocks the substrate-binding site in its kinase domain, makes the cytoplasmic form of PKC inactive.
    Protein Kinase C (19-35) Peptide
  • HY-P3916
    GVLSNVIGYLKKLGTGALNAVLKQ 136831-50-0 98%
    GVLSNVIGYLKKLGTGALNAVLKQ is an antimicrobial peptide with 24-amino acid. GVLSNVIGYLKKLGTGALNAVLKQ can potentially form α-helix. GVLSNVIGYLKKLGTGALNAVLKQ (PGQ) has activity against Gram-negative, Gram-positive bacteria and the yeast Candida albicans.
    GVLSNVIGYLKKLGTGALNAVLKQ
  • HY-P3933
    [Tyr8,Nle11] Substance P 71890-48-7 98%
    [Tyr8,Nle11] Substance P is a Substance P (HY-P0201) analog. Substance P is a peptide mainly secreted by neurons and is involved in many biological processes, including nociception and inflammation.
    [Tyr8,Nle11] Substance P
  • HY-P3963
    Thymus Factor 62036-77-5 98%
    Thymus Factor (Thymulin) is a key factor responsible for the maturation of humoral immunological faculty. Thymulin is an inhibitor of ERK.
    Thymus Factor
  • HY-P3966
    Thymosin β10Arg 88160-82-1 98%
    Thymosin β10Arg is a thymosin β4-like peptide that contains an additional amino acid, arginine, inserted following lysine-38.
    Thymosin β10Arg
  • HY-P3970
    KRFK 162290-78-0 98%
    KRFK, a peptide derived from TSP-1, can activate TGF-β. KRFK promotes TGF-β-mediated signaling and its downstream role, independent of thrombospondin (TSP) receptors such as CD47 and CD36. KRFK can be used for chronic ocular surface inflammatory disorders reseach.
    KRFK
  • HY-P3971
    H-Leu-Ser-Lys-Leu-OH 162559-45-7 98%
    H-Leu-Ser-Lys-Leu-OH (LSYL) is a latency-associated peptide at the amino terminus of LAP, with inhibitory effect on TGF-β1 activation. H-Leu-Ser-Lys-Leu-OH, binding with KRFK (HY-P3970), can block the signal transduction of TGF-β1, and prevent the progression of hepatic damage and fibrosis.
    H-Leu-Ser-Lys-Leu-OH
  • HY-P3977
    ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) 1036763-00-4 98%
    ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) is the 3-24 fragment of adrenocorticotropic hormone (ACTH). ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) can be used for research of a variety of diseases, including cancer, immune diseases, cardiovascular disease.
    ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat)
  • HY-P4013
    [Arg15,20,21, Leu17] VIP-Gly-Lys-Arg-NH2 186844-13-3 98%
    [Arg15,20,21, Leu17] VIP-Gly-Lys-Arg-NH2 is a vasoactive intestinal polypeptide (VIP) analog with relaxant effects.
    [Arg15,20,21, Leu17] VIP-Gly-Lys-Arg-NH2
  • HY-P4014
    HSDAVFTDNYTRLRRQLAVRRYLNSILN-NH2 735327-71-6 98%
    HSDAVFTDNYTRLRRQLAVRRYLNSILN-NH2 is an anti-inflammatory peptide.
    HSDAVFTDNYTRLRRQLAVRRYLNSILN-NH2
  • HY-P4031
    HCV Peptide (131-140) 160926-86-3 98%
    HCV Peptide (131-140) is a peptide. HCV Peptide (131-140) can be used for the research of hepatitis C virus (HCV) .
    HCV Peptide (131-140)
  • HY-P4033
    HCV Peptide (257-266) 199533-16-9 98%
    HCV Peptide (257-266) is a peptide. HCV Peptide (257-266) can be used for the research of hepatitis C virus (HCV) .
    HCV Peptide (257-266)
  • HY-P4040
    Ac-D-DGla-LI-Cha-C 208940-40-3 98%
    Ac-D-DGla-LI-Cha-C is a potent HCV protease inhibitor peptide. Ac-D-DGla-LI-Cha-C can be used for the research of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases.
    Ac-D-DGla-LI-Cha-C
  • HY-P4042
    Hepatitis B Virus Receptor Binding Fragment 114495-85-1 98%
    Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) is a synthetic peptide analog which specifically binds to Hep G2 cells. Hepatitis B Virus Receptor Binding Fragment is a promising immunogen expected to elicit protective antibodies based on the concept of the attachment blockade pathway of virus neutralization.
    Hepatitis B Virus Receptor Binding Fragment
  • HY-P4043
    Hepatitis b virus pre-s region (120-145) 104504-34-9 98%
    Hepatitis b virus pre-s region (120-145) is a preS2 peptide that inhibits the binding of single-chain Fv fragment (scFv) or IgG to r-HBsAg.
    Hepatitis b virus pre-s region (120-145)
  • HY-P4046
    HBV Seq2 aa:179-186 337464-42-3 98%
    HBV Seq2 aa:179-186 serve as effective motifs for CTL response in H-2b system after in vitro restimulation of the primed T cells. HBV Seq2 aa:179-186 is a novel epitope identified on the surface antigen of hepatitis B virus.
    HBV Seq2 aa:179-186
Cat. No. Product Name / Synonyms Application Reactivity